(PDF) P3.15-12 Survival Impact of Patient Enrollment in

P3.15-12 Survival Impact of Patient Enrollment in Antineoplastic Drug Trials for Stage IV Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1888

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P3.15-30 Treatment Patterns and Survival of Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) in the Era of Novel Therapies

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.15-28 Real World Treatment Patterns and Survival of Stage IV Non-Small Cell Lung Cancer (NSCLC) in Ontario, Canada

Journal of Thoracic Oncology

Respiratory Medicine

English

PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) Treatments

Value in Health

Occupational Health

English

Pembrolizumab-Induced Obstructive Bronchiolitis in a Patient With Stage IV Non-Small-Cell Lung Cancer

Current Oncology

English

P3.15-012 Surgical Outcome in Early Stage Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

MA25.05 Characteristics and Survival of Resected Stage IV Non-Small Cell Lung Cancer (NSCLC) in the Mid-South Quality of Surgical Resection Cohort

Journal of Thoracic Oncology

Respiratory Medicine

English

Image Features for the Future in Stage IV Non-Small Cell Lung Cancer

English

(S011) Does Insurance Status Impact Survival Outcomes in Patients With Stage III Non-Small Cell Lung Cancer (NSCLC) Treated With Curative Intent?

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

P3.15-10 Survival Impact of Peripheral Blood Ratios in Lung Cancer According Clinical Stage

Journal of Thoracic Oncology

Respiratory Medicine

English